These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 19330167

  • 1. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K, Fiers W, Saelens X.
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [Abstract] [Full Text] [Related]

  • 2. M2e-based universal influenza A vaccine.
    Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X.
    Vaccine; 2009 Oct 23; 27(45):6280-3. PubMed ID: 19840661
    [Abstract] [Full Text] [Related]

  • 3. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D.
    Cell Immunol; 2001 Aug 01; 211(2):143-53. PubMed ID: 11591118
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S, Tanimoto T, Kurata T.
    Jpn J Infect Dis; 2005 Aug 01; 58(4):195-207. PubMed ID: 16116250
    [Abstract] [Full Text] [Related]

  • 5. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
    Ernst WA, Kim HJ, Tumpey TM, Jansen AD, Tai W, Cramer DV, Adler-Moore JP, Fujii G.
    Vaccine; 2006 Jun 12; 24(24):5158-68. PubMed ID: 16713037
    [Abstract] [Full Text] [Related]

  • 6. Vaccines to protect humans from pandemic avian influenza strains.
    Campbell JD.
    Md Med; 2006 Jun 12; 7(1):15-8. PubMed ID: 16613361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
    Wu F, Yuan XY, Huang WS, Chen YH.
    Vaccine; 2009 Oct 09; 27(43):6095-101. PubMed ID: 19056447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A, Janulíková J, Varecková E.
    Acta Virol; 2010 Oct 09; 54(1):7-19. PubMed ID: 20201609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
    Eliasson DG, El Bakkouri K, Schön K, Ramne A, Festjens E, Löwenadler B, Fiers W, Saelens X, Lycke N.
    Vaccine; 2008 Feb 26; 26(9):1243-52. PubMed ID: 18243429
    [Abstract] [Full Text] [Related]

  • 15. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.
    Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, Xu L, Nabel GJ.
    Vaccine; 2005 Nov 16; 23(46-47):5404-10. PubMed ID: 16011865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E, Liang X, Ingallinella P, Finotto M, Chastain MA, Fan J, Fu TM, Song HC, Horton MS, Freed DC, Manger W, Wen E, Shi L, Ionescu R, Price C, Wenger M, Emini EA, Cortese R, Ciliberto G, Shiver JW, Pessi A.
    J Virol; 2005 Jun 16; 79(12):7380-8. PubMed ID: 15919893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.